July 27, 2015

The FDA has approved Daklinza (daclatasvir), in combination with sofosbuvir, in treatment for chronic hepatitis C virus genotype 3 infections.  

July 27, 2015

The Food and Drug administration announced Friday that it had approved Praluent (alirocumab), a cholesterol-lowering PCSK9 inhibitor injection. 

July 27, 2015

As the sole U.S. supplier of fluoxymesterone, Upsher-Smith sought a way to renew the product’s availability after the company’s initial API manufacturer discontinued its supply. 

July 24, 2015

On Friday, Stichting Preferred Shares Mylan, an independent foundation established in the Netherlands, announced that it would exercise its full call option to purchase 488,388,431 preferred shares in Mylan.

July 24, 2015

The Food and Drug Administration announced Friday that it approved Technivie (ombitasvir, paritaprevir and ritonavir) for use in combination with ribavirin for the treatment of hepatitis C virus (HCV) genotype 4 infections in patients without scarring and cirrhosis.

July 24, 2015

The Food and Drug Administration announced Friday that it had approved Novartis’ Odomzo (sonidegib). The drug is meant to treat basal cell carcinoma, the most common form of advanced skin cancer.

July 22, 2015

Novartis will be able to introduce Sandoz’s Zarxio (filgrastim) after Sept. 2, the U.S. Court of Appeal for the Federal Circuit ruled Wednesday. 

July 20, 2015

Access to healthcare drove 82.9% more blood pressure screenings and 26.9% more diabetes screenings.

July 20, 2015

Patients surfing the content on Elsevier's Health Library can search by a specific condition or diagnosis or move through an easy-to-skim, A-to-Z list of healthcare topics.

July 17, 2015

Amneal Pharmaceuticals has introduced four new products since June.

July 16, 2015

Galderma Laboratories announced Thursday that the Food and Drug Administration had approved it Epiduo Forte Gel, an antibiotic-free daily treatment for acne vulgaris.

July 16, 2015

As many as 12% of pet owners have bought health insurance for their animals. And among millennials, that number jumps to 19%. 

July 16, 2015

Increasing access to birth control through the pharmacy may pose a challenge - will pharmacists who counsel patients on family planning be reimbursed for their efforts?

July 15, 2015

The Food and Drug Administration is exploring extending PDUFA through 2022. 

July 15, 2015

Almost half of all people in an employer wellness program and with a chronic condition learned of their health status through that wellness program. 

July 15, 2015

The new guidelines have been expected to increase the number of statin-eligible adults by almost 13 million.

July 14, 2015

America’s biopharmaceutical research companies are currently developing 420 medicines for patients suffering from neurological disorders, including epilepsy, Alzheimer’s disease, multiple sclerosis and Parkinson’s disease. 

July 14, 2015

During the 2013-2014 season, the CDC estimated influenza vaccination prevented 7.2 million influenza-associated illnesses, 3.1 million medically attended illnesses and 90,000 hospitalizations.

July 13, 2015

Illinois may be about to place a lock down on all prescribed hydrocodone painkillers. 

July 13, 2015

The Food and Drug Administration warns patients that prolonged use of NSAIDs could increase risk of heart attack or stroke. 

July 13, 2015

The White House has nominated Andy Slavitt, an advocate of data-driven health innovation, to serve as the Centers for Medicare and Medicaid Services’ administrator. 

July 13, 2015

The average lost time worker's compensation claim for workers using opioid painkillers can total as much as $117,000 — 900% higher than the cost for workers who do not take opioid painkillers, the National Safety Council says. 

July 13, 2015

Otsuka Pharmaceutical and H. Lundbeck A/S announced Friday that their new medication Rexulti (brexpiprazole) had been approved by the Food and Drug Administration as an adjunctive treatment for major depressive disorder (MDD) and a treament for schizophrenia.